Discover 1,943 paid clinical trials in Fort Worth, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Fort Worth offers a range of medical research opportunities, focusing on conditions such as cancer, cardiovascular disease, PTSD, and COVID-19. Healthy volunteers looking for paid opportunities, as well as those with specific health concerns, can participate in studies at the city’s leading healthcare facilities, gaining access to new and innovative treatments while contributing to advancements in medical research.
Filter
2
Filter results
Results: 1,943
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
Location: Plano TX, Clearwater FL, Pomona NJ, New York NY,
Sponsor: Concept Medical Inc.
Sex: All
Age: 18 - 70+
Code: NCT06271590
Recruiting
Efficacy and Safety of 4F-PCC (4-Factor Prothrombin Complex Concentrate) in Adult Patients Undergoing Complex Cardiovascular Surgery With Cardiopulmonary Bypass (CPB)
for
Complex Cardiovascular Surgery With Cardiopulmonary Bypass
Location: Dallas TX, Oklahoma City OK, Chicago IL, Cincinnati OH,
Sponsor: CSL Behring
Sex: All
Age: 18+
Code: NCT07094087
Phase 3, Recruiting
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
for
Viral Lung Infection and Acute Respiratory Failure
Location: Dallas TX, Oklahoma City OK, Baton Rouge LA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT05624450
Phase 3, Recruiting
Milrinone for Prevention of Post-ligation Cardiac Syndrome Trial
for
Post-ligation Cardiac Syndrome
Location: Dallas TX, Oklahoma City OK, Houston TX, Memphis TN,
Sponsor: NICHD Neonatal Research Network
Sex: All
Age: 0
Code: NCT06679855
Phase 3, Recruiting
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
Study to Compare the Overall Survival of Patients Receiving INGN 201 (Study Drug) With Patients Receiving Methotrexate
for
Carcinoma, Squamous Cell
Location: Dallas TX, Aurora CO, Louisville KY, Columbia SC,
Sponsor: Introgen Therapeutics
Sex: All
Age: 18+
Code: NCT00041613
Phase 3, Recruiting
A Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated Dystonia
for
Dystonia
Location: Dallas TX, Georgetown TX, Houston TX, Overland Park KS,
Sponsor: Vima Therapeutics
Sex: All
Age: 18 - 70
Code: NCT07304089
Phase 2, Recruiting
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Dallas TX, Austin TX, San Antonio TX, Houston TX,